Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT03211351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95
Last updated 2018-02-26
Summary
With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been developed in which phospholipid liposomes are delivered to the tear film via the surface of the closed eyelid. This study compare the effects of Liposic and Tears Naturale Forte application on the lipid and stability of the tear film in dry eye patients
Conditions
- Dry Eye
- Tear Film
- Lipid Layer
- Liposic
- Tears Naturale Forte
Interventions
- DRUG
-
Liposic
one eye of the participant recieved Lipoic
- DRUG
-
Tears Naturale Forte
the other eye of the participant recieved Tears Naturale Forte
Sponsors & Collaborators
-
Huaxia Eye Hospital Group
lead OTHER
Principal Investigators
-
Chi Zhang, MD.PhD · Huaxia Eye Hospital of Foshan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-07-01
- Primary Completion
- 2017-12-01
- Completion
- 2018-01-25
Countries
- China
Study Locations
More Related Trials
-
Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation
NCT04633863 ·Status: COMPLETED ·Phase: NA
-
Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02824913 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
NCT00932477 ·Status: COMPLETED ·Phase: NA
-
Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
NCT02958514 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of HE10 for Dry Eye Syndrome
NCT02492412 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
NCT06544694 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Designed to Evaluate Tear Production
NCT06544707 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease
NCT06188260 ·Status: COMPLETED ·Phase: PHASE2
-
Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye
NCT03815539 ·Status: UNKNOWN ·Phase: NA
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT00622037 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients With Dry Eye After LASIK
NCT07097922 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
NCT04393441 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
NCT07078955 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes
NCT01804361 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers
NCT02102464 ·Status: COMPLETED ·Phase: NA
-
Study of the TearCare System in Dry Eye Disease
NCT03588624 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
NCT00788229 ·Status: COMPLETED ·Phase: PHASE2
-
Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes
NCT01363414 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye
NCT06752278 ·Status: COMPLETED ·Phase: NA
-
Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT
NCT06981104 ·Status: COMPLETED ·Phase: NA
-
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
NCT03492541 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Different Hyaluronic Acid Tear Substitutes Formulations in Evaporative Dry Eye
NCT06517667 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry Eye
NCT03074344 ·Status: COMPLETED ·Phase: NA
-
Tear Osmolarity Clinical Utility in Dry Eye Disease
NCT02417116 ·Status: COMPLETED ·Phase: NA